Abstract
Tetrahydrogestrinone (THG) was recently identified as a novel steroid used illicitly to improve athletic performance. Although its structure is closely related to gestrinone, a 19-nor progestin, and resembles that of trenbolone, THG was never marketed, so information on its hormonal properties is not known. In this study, we demonstrate that THG is a highly potent androgen and progestin in a yeast-based in vitro bioassay system expressing human androgen and progesterone receptors. It has no estrogenic activity and no antagonism for any of the three steroid receptor classes.
MeSH terms
-
Androgens / administration & dosage
-
Androgens / pharmacology*
-
Biological Assay
-
Dose-Response Relationship, Drug
-
Gestrinone / administration & dosage
-
Gestrinone / analogs & derivatives
-
Gestrinone / pharmacology*
-
Humans
-
Nandrolone / administration & dosage
-
Progestins / administration & dosage
-
Progestins / pharmacology*
-
Receptors, Androgen / genetics
-
Receptors, Androgen / metabolism
-
Receptors, Estrogen / metabolism
-
Receptors, Progesterone / metabolism
-
Transcriptional Activation / drug effects
-
Trenbolone Acetate / administration & dosage
-
Yeasts
Substances
-
Androgens
-
Progestins
-
Receptors, Androgen
-
Receptors, Estrogen
-
Receptors, Progesterone
-
Gestrinone
-
tetrahydrogestrinone
-
Nandrolone
-
Trenbolone Acetate